Six whistleblowers scored a major victory Thursday when the global consumer goods conglomerate Reckitt Benckiser Group announced a record $1.4 billion civil settlement with the federal government over sales and marketing of the opioid Suboxone.

The U.S. Department of Justice said the RB Group also entered a nonprosecution agreement to resolve potential criminal charges. The settlement included the U.K.-based group and its subsidiary in New Jersey, Reckitt Benckiser LLC.